Nnit AS (NNIT) - Total Liabilities
Based on the latest financial reports, Nnit AS (NNIT) has total liabilities worth Dkr731.00 Million DKK (≈ $114.37 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NNIT cash flow metrics to assess how effectively this company generates cash.
Nnit AS - Total Liabilities Trend (2010–2025)
This chart illustrates how Nnit AS's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Nnit AS to evaluate the company's liquid asset resilience ratio.
Nnit AS Competitors by Total Liabilities
The table below lists competitors of Nnit AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$3.96 Billion |
|
Ekovest Bhd
KLSE:8877
|
Malaysia | RM8.28 Billion |
|
Protalix Biotherapeutics Inc
NYSE MKT:PLX
|
USA | $34.12 Million |
|
DAEYANG ELECTRIC.Co.Ltd
KQ:108380
|
Korea | ₩52.78 Billion |
|
Bitcoin Group SE
XETRA:ADE
|
Germany | €102.52 Million |
|
Anteris Technologies Global Corp. Common Stock
NASDAQ:AVR
|
USA | $15.71 Million |
|
Plenitude Bhd
KLSE:5075
|
Malaysia | RM771.64 Million |
|
Froch Enterprise Co Ltd
TW:2030
|
Taiwan | NT$6.54 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down Nnit AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nnit AS market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nnit AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nnit AS (2010–2025)
The table below shows the annual total liabilities of Nnit AS from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr731.00 Million ≈ $114.37 Million |
-12.66% |
| 2024-12-31 | Dkr837.00 Million ≈ $130.95 Million |
-27.22% |
| 2023-12-31 | Dkr1.15 Billion ≈ $179.93 Million |
-40.72% |
| 2022-12-31 | Dkr1.94 Billion ≈ $303.53 Million |
+17.22% |
| 2021-12-31 | Dkr1.66 Billion ≈ $258.94 Million |
+8.31% |
| 2020-12-31 | Dkr1.53 Billion ≈ $239.07 Million |
+5.82% |
| 2019-12-31 | Dkr1.44 Billion ≈ $225.92 Million |
-1.05% |
| 2018-12-31 | Dkr1.46 Billion ≈ $228.33 Million |
+77.38% |
| 2017-12-31 | Dkr822.71 Million ≈ $128.72 Million |
+10.57% |
| 2016-12-31 | Dkr744.05 Million ≈ $116.41 Million |
+25.06% |
| 2015-12-31 | Dkr594.96 Million ≈ $93.09 Million |
-0.53% |
| 2014-12-31 | Dkr598.16 Million ≈ $93.59 Million |
+17.06% |
| 2013-12-31 | Dkr510.98 Million ≈ $79.95 Million |
-6.47% |
| 2012-12-31 | Dkr546.30 Million ≈ $85.47 Million |
+16.85% |
| 2011-12-31 | Dkr467.53 Million ≈ $73.15 Million |
+13.03% |
| 2010-12-31 | Dkr413.63 Million ≈ $64.72 Million |
-- |
About Nnit AS
NNIT A/S provides information technology solutions for life sciences, public, and private sectors in Denmark, Europe, the United States, and Asia. The company provides cybersecurity, regulatory affairs, AI, laboratory, drug safety, compliance, quality, SAP solutions, software engineering, digital manufacturing, clinical, data and cloud, supply chain, tech transition consulting, legacy transformat… Read more